234 related articles for article (PubMed ID: 2549986)
1. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
Hwang SB
Biochem Biophys Res Commun; 1989 Aug; 163(1):165-71. PubMed ID: 2549986
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
Hwang SB; Lam MH; Chang MN
J Biol Chem; 1986 Oct; 261(29):13720-6. PubMed ID: 3020044
[TBL] [Abstract][Full Text] [Related]
3. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
Hwang SB; Lam MH; Hsu AH
Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
[TBL] [Abstract][Full Text] [Related]
5. L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.
Hwang SB; Lam MH
Lipids; 1991 Dec; 26(12):1148-53. PubMed ID: 1668109
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
[TBL] [Abstract][Full Text] [Related]
7. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
8. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
Herbert JM; Laplace MC; Maffrand JP
J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
Terashita Z; Imura Y; Nishikawa K
Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor.
Paulson SK; Wolf JL; Novotney-Barry A; Cox CP
Proc Soc Exp Biol Med; 1990 Nov; 195(2):247-54. PubMed ID: 2172997
[TBL] [Abstract][Full Text] [Related]
12. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard method.
Balsa D; Merlos M; Giral M; Ferrando R; García-Rafanell J; Forn J
J Pharmacol Toxicol Methods; 1996 Sep; 36(1):53-62. PubMed ID: 8872920
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
15. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.
Hwang SB
J Biol Chem; 1988 Mar; 263(7):3225-33. PubMed ID: 2830276
[TBL] [Abstract][Full Text] [Related]
16. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes.
Chau LY; Tsai YM; Cheng JR
Biochem Biophys Res Commun; 1989 Jun; 161(3):1070-6. PubMed ID: 2545193
[TBL] [Abstract][Full Text] [Related]
17. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
Tahraoui L; Floch A; Cavero I
J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
[TBL] [Abstract][Full Text] [Related]
18. A specific, photolabile and irreversible antagonist (L662,025) of the PAF-receptor.
Hussaini IM; Shen TY
Biochem Biophys Res Commun; 1989 May; 161(1):23-30. PubMed ID: 2543410
[TBL] [Abstract][Full Text] [Related]
19. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
[TBL] [Abstract][Full Text] [Related]
20. Radioligand competitive binding methodology for the evaluation of platelet-activating factor (PAF) and PAF-receptor antagonism using intact canine platelets.
Janero DR; Burghardt B; Burghardt C
J Pharmacol Methods; 1988 Nov; 20(3):237-53. PubMed ID: 2853256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
